This work translated the preceding metal-catalyzed tryptophan modification method into a metal-free process, enabling efficient labeling of peptides, proteins, and even cell lysates in hexafluoroisopropanol (HFIP).
While their broad utility in various chemistry fields were well recognized for decades, fluoroalcohols have recently emerged as a unique solvent system for bioconjugation development. This review describes examples and roles of fluoroalcohols such as trifluoroethanol (TFE) and hexafluoroisopropanol (HFIP) for chemical modification of biomolecules such as polypeptides, nucleic acids, and saccharides. Many chemical modification processes were facilitated by notable functions of those fluoroalcohols such as a proton shuttle, reversible adduct formation with reactive species, and compatibility with electrochemistry/photochemistry. The usefulness of the fluoroalcohol solvents can be even promoted by its combination with a different solvent system for reaction enhancement and protein stabilization. The collection of the various chemical transformations in this review is an indication of the rapid growth of the solvent-assisted bioconjugation field.
A set of 74 small molecules was employed to generate a quantitative structure-property relationship (QSPR) model for predicting gas-phase Gibb’s free energy changes (ΔGgas) on the simplified molecular input line entry system (SMILES). To obtain the models, the Monte Carlo method (MCM) was applied to calculate the descriptors. The best proposed model of them provides an excellent statistical result of r2 = 0.9866, q2 = 0.9857, s = 2.48 and F = 4346 for the training set, and r2 = 0.9340, q2 = 0.8418, s = 5.80, F = 149 for the test set. Consequently, the gas-phase Gibb’s free energy changes were also calculated in DFT (MPW1PW91/6-311+G(2d,2p)), CBS-QB3, G1, G2 and G2MP2 methods which showed a very good agreement with experimental values.
The novel coronavirus, COVID-19, caused by SARS-CoV-2, is a global health pandemic and currently no specific drug is available to prevent or cure this novel coronavirus (SARS-CoV-2) disease. We have been put forth five pyrimidine ring containing compounds as potential antiviral candidatures for the treatment of COVID-19 diseases based on quantum chemical properties predicted by molecular docking study and DFT calculations at the level of B3LYP method with 6-311++G (d,p) basis set. Our findings were also compared to remdesivir, a control ligand. Blind docking with the main protease revealed that the ligands preferentially bind to the active site. Interestingly, all of the ligands exhibited low binding free energies i.e., strong inhibitory interactions with the active sites of the main protease. Ligand L1 was one of them, which revealed significantly low binding energies (-8.8 kcal/mol) with SARS-CoV-2 Mpro. These binding energies are even lower than those of remdesivir’s potent active metabolite. All of the drugs interact with the key active site residues, including His41 and Cys145. These findings are also strongly supported by quantum chemical investigations.